| Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity PA Gurbel, KP Bliden, BL Hiatt, CM O’Connor Circulation 107 (23), 2908-2913, 2003 | 2211 | 2003 |
| Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy AR Shuldiner, JR O’Connell, KP Bliden, A Gandhi, K Ryan, ... Jama 302 (8), 849-857, 2009 | 1778 | 2009 |
| Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the … PA Gurbel, KP Bliden, K Butler, US Tantry, T Gesheff, C Wei, R Teng, ... Circulation 120 (25), 2577-2585, 2009 | 1488 | 2009 |
| Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis JL Mega, T Simon, JP Collet, JL Anderson, EM Antman, K Bliden, ... Jama 304 (16), 1821-1830, 2010 | 1404 | 2010 |
| Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study PA Gurbel, KP Bliden, K Guyer, PW Cho, KA Zaman, RP Kreutz, AK Bassi, ... Journal of the American College of Cardiology 46 (10), 1820-1826, 2005 | 862 | 2005 |
| Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study PA Gurbel, KP Bliden, W Samara, JA Yoho, K Hayes, MZ Fissha, ... Journal of the American College of Cardiology 46 (10), 1827-1832, 2005 | 757 | 2005 |
| Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study PA Gurbel, KP Bliden, K Butler, MJ Antonino, C Wei, R Teng, ... Circulation 121 (10), 1188-1199, 2010 | 676 | 2010 |
| Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study PA Gurbel, KP Bliden, J DiChiara, J Newcomer, W Weng, NK Neerchal, ... Circulation 115 (25), 3156-3164, 2007 | 547 | 2007 |
| Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet … KP Bliden, J DiChiara, US Tantry, AK Bassi, SK Chaganti, PA Gurbel Journal of the American College of Cardiology 49 (6), 657-666, 2007 | 546 | 2007 |
| The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting PA Gurbel, KP Bliden, KM Hayes, JA Yoho, WR Herzog, US Tantry Journal of the American College of Cardiology 45 (9), 1392-1396, 2005 | 536 | 2005 |
| Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis EP Navarese, JG Robinson, M Kowalewski, M Kołodziejczak, F Andreotti, ... Jama 319 (15), 1566-1579, 2018 | 495 | 2018 |
| Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR … PA Gurbel, KP Bliden, KA Zaman, JA Yoho, KM Hayes, US Tantry Circulation 111 (9), 1153-1159, 2005 | 488 | 2005 |
| Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation US Tantry, KP Bliden, PA Gurbel Journal of the American College of Cardiology 46 (9), 1705-1709, 2005 | 473 | 2005 |
| Platelet Function Measurement–Based Strategy to Reduce Bleeding and Waiting Time in Clopidogrel-Treated Patients Undergoing Coronary Artery Bypass Graft Surgery: The Timing … E Mahla, TA Suarez, KP Bliden, P Rehak, H Metzler, AJ Sequeira, P Cho, ... Circulation: Cardiovascular Interventions 5 (2), 261-269, 2012 | 315 | 2012 |
| The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study J DiChiara, KP Bliden, US Tantry, MS Hamed, MJ Antonino, TA Suarez, ... Diabetes 56 (12), 3014-3019, 2007 | 293 | 2007 |
| The association of cigarette smoking with enhanced platelet inhibition by clopidogrel KP Bliden, J DiChiara, L Lawal, A Singla, MJ Antonino, BA Baker, ... Journal of the American College of Cardiology 52 (7), 531-533, 2008 | 278 | 2008 |
| First Analysis of the Relation Between CYP2C19 Genotype and Pharmacodynamics in Patients Treated With Ticagrelor Versus Clopidogrel: The ONSET/OFFSET … US Tantry, KP Bliden, C Wei, RF Storey, M Armstrong, K Butler, PA Gurbel Circulation: Cardiovascular Genetics 3 (6), 556-566, 2010 | 245 | 2010 |
| Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET … RF Storey, KP Bliden, SB Patil, A Karunakaran, R Ecob, K Butler, R Teng, ... Journal of the American College of Cardiology 56 (3), 185-193, 2010 | 235 | 2010 |
| Adenosine diphosphate–induced platelet-fibrin clot strength: A new thrombelastographic indicator of long-term poststenting ischemic events PA Gurbel, KP Bliden, IA Navickas, E Mahla, J Dichiara, TA Suarez, ... American heart journal 160 (2), 346-354, 2010 | 220 | 2010 |
| The difference between clopidogrel responsiveness and posttreatment platelet reactivity WM Samara, KP Bliden, US Tantry, PA Gurbel Thrombosis research 115 (1-2), 89-94, 2005 | 208 | 2005 |
